Clin Colon Rectal Surg 2010; 23(4): 259-268
DOI: 10.1055/s-0030-1268252
© Thieme Medical Publishers

Diagnosis and Management of Postoperative Ileal Pouch Disorders

Bo Shen1
  • 1Department of Gastroenterology/Hepatology, Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio
Further Information

Publication History

Publication Date:
07 December 2010 (online)

ABSTRACT

Although restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) has become the surgical treatment of choice for patients with refractory ulcerative colitis (UC) or UC with dysplasia, surgical, inflammatory, and noninflammatory adverse sequelae are common. Pouchitis, representing a spectrum of disease phenotypes, is the most common long-term complication of IPAA. De novo Crohn disease (CD) of the pouch can occur in patients with a preoperative diagnosis of UC. Differential diagnosis between fibrostenotic or fistulizing CD and surgery-associated strictures, sinuses, and fistulas often requires a combined assessment of symptom, endoscopy, histology, radiography, and examination under anesthesia. There is a role for endoscopic therapy for stricturing complications of IPAA. Chronic antibiotic-refractory pouchitis, refractory cuffitis, as well as fibrostenotic or fistulizing CD of the pouch are the leading late-onset causes for pouch failure.

REFERENCES

  • 1 Hueting W E, Buskens E, van der Tweel I, Gooszen H G, van Laarhoven C J. Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients.  Dig Surg. 2005;  22(1-2) 69-79
  • 2 Sagap I, Remzi F H, Hammel J P, Fazio V W. Factors associated with failure in managing pelvic sepsis after ileal pouch-anal anastomosis (IPAA)—a multivariate analysis.  Surgery. 2006;  140(4) 691-703 discussion 703-704
  • 3 Prudhomme M, Dehni N, Dozois R R, Tiret E, Parc R. Causes and outcomes of pouch excision after restorative proctocolectomy.  Br J Surg. 2006;  93(1) 82-86
  • 4 Nicholls R J. Review article: ulcerative colitis—surgical indications and treatment.  Aliment Pharmacol Ther. 2002;  16(Suppl 4) 25-28
  • 5 Shen B, Lian L, Remzi F H et al.. Natural history of cuffitis in ulcerative colitis patients with restorative proctocolectomy and ileal pouch-anal anastomosis. Poster presented at: Digestive Disease Week May 1–10, 2010 New Orleans, LA;
  • 6 Garrett K A, Remzi F H, Kirat H T, Fazio V W, Shen B, Kiran R P. Outcome of salvage surgery for ileal pouches referred with a diagnosis of Crohn's disease.  Dis Colon Rectum. 2009;  52(12) 1967-1974
  • 7 Paye F, Penna C, Chiche L, Tiret E, Frileux P, Parc R. Pouch-related fistula following restorative proctocolectomy.  Br J Surg. 1996;  83(11) 1574-1577
  • 8 Hedrick T L, Sawyer R G, Foley E F, Friel C M. Anastomotic leak and the loop ileostomy: friend or foe?.  Dis Colon Rectum. 2006;  49(8) 1167-1176
  • 9 Meagher A P, Farouk R, Dozois R R, Kelly K A, Pemberton J H. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients.  Br J Surg. 1998;  85(6) 800-803
  • 10 Tang L, Cai H, Moore L, Shen B.. Evaluation of endoscopic and imaging modalities in the diagnosis of structural disorders of the ileal pouch.  Inflamm Bowel Dis. 2010;  16(9) 1526-1531
  • 11 Swain B T, Ellis C N. Fibrin glue treatment of low rectal and pouch-anal anastomotic sinuses.  Dis Colon Rectum. 2004;  47(2) 253-255
  • 12 Whitlow C B, Opelka F G, Gathright Jr J B, Beck D E. Treatment of colorectal and ileoanal anastomotic sinuses.  Dis Colon Rectum. 1997;  40(7) 760-763
  • 13 Lian L, Geisler D, Shen B. Endoscopic needle knife treatment of chronic presacral sinus at the anastomosis at an ileal pouch-anal anastomosis.  Endoscopy. 2010;  42(Suppl 2) E14
  • 14 Shah N S, Remzi F, Massmann A, Baixauli J, Fazio V W. Management and treatment outcome of pouch-vaginal fistulas following restorative proctocolectomy.  Dis Colon Rectum. 2003;  46(7) 911-917
  • 15 Rochey H, Navaneethan U, Kiran R, Shen B. Evaluation of diagnostic modalities for pouch vaginal fistula in patients with inflammatory bowel disease and restorative proctocolectomy. Paper presented at: American College of Gastroenterology Annual Meeting October 18–20, 2010 San Antonio,TX;
  • 16 Burke D, van Laarhoven C J, Herbst F, Nicholls R J. Transvaginal repair of pouch-vaginal fistula.  Br J Surg. 2001;  88(2) 241-245
  • 17 Prudhomme M, Dozois R R, Godlewski G, Mathison S, Fabbro-Peray P. Anal canal strictures after ileal pouch-anal anastomosis.  Dis Colon Rectum. 2003;  46(1) 20-23
  • 18 Shen B, Fazio V W, Remzi F H et al.. Endoscopic balloon dilation of ileal pouch strictures.  Am J Gastroenterol. 2004;  99(12) 2340-2347
  • 19 Lucha Jr P A, Fticsar J E, Francis M J. The strictured anastomosis: successful treatment by corticosteroid injections—report of three cases and review of the literature.  Dis Colon Rectum. 2005;  48(4) 862-865
  • 20 Shen B, Fazio V W, Remzi F H et al.. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses.  Am J Gastroenterol. 2005;  100(1) 93-101
  • 21 Penna C, Dozois R, Tremaine W et al.. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.  Gut. 1996;  38(2) 234-239
  • 22 Fazio V W, Ziv Y, Church J M et al.. Ileal pouch-anal anastomoses complications and function in 1005 patients.  Ann Surg. 1995;  222(2) 120-127
  • 23 Gionchetti P, Rizzello F, Helwig U et al.. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.  Gastroenterology. 2003;  124(5) 1202-1209
  • 24 Penna C, Tiret E, Kartheuser A, Hannoun L, Nordlinger B, Parc R. Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis.  Br J Surg. 1993;  80(6) 765-767
  • 25 Tjandra J J, Fazio V W, Church J M, Oakley J R, Milsom J W, Lavery I C. Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis.  Am J Surg. 1993;  165(3) 322-325
  • 26 Gosselink M P, Schouten W R, van Lieshout L MC, Hop W C, Laman J D, Ruseler-van Embden J G. Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG.  Dis Colon Rectum. 2004;  47(6) 876-884
  • 27 Gionchetti P, Rizzello F, Venturi A et al.. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.  Gastroenterology. 2000;  119(2) 305-309
  • 28 Mimura T, Rizzello F, Helwig U et al.. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.  Gut. 2004;  53(1) 108-114
  • 29 Carter M J, Di Giovine F S, Cox A et al.. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis.  Gastroenterology. 2001;  121(4) 805-811
  • 30 Brett P M, Yasuda N, Yiannakou J Y et al.. Genetic and immunological markers in pouchitis.  Eur J Gastroenterol Hepatol. 1996;  8(10) 951-955
  • 31 Aisenberg J, Legnani P E, Nilubol N et al.. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients.  Am J Gastroenterol. 2004;  99(3) 432-441
  • 32 Meier C B, Hegazi R A, Aisenberg J et al.. Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor?.  Inflamm Bowel Dis. 2005;  11(11) 965-971
  • 33 Schmidt C M, Lazenby A J, Hendrickson R J, Sitzmann J V. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure.  Ann Surg. 1998;  227(5) 654-662 discussion 663-665
  • 34 Achkar J P, Al-Haddad M, Lashner B et al.. Differentiating risk factors for acute and chronic pouchitis.  Clin Gastroenterol Hepatol. 2005;  3(1) 60-66
  • 35 Okon A, Dubinsky M, Vasiliauskas E A et al.. Elevated platelet count before ileal pouch-anal anastomosis for ulcerative colitis is associated with the development of chronic pouchitis.  Am Surg. 2005;  71(10) 821-826
  • 36 Fleshner P, Ippoliti A, Dubinsky M et al.. A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis.  Clin Gastroenterol Hepatol. 2007;  5(8) 952-958, quiz 887
  • 37 Shepherd N A, Hultén L, Tytgat G NJ et al.. Pouchitis.  Int J Colorectal Dis. 1989;  4(4) 205-229
  • 38 Lohmuller J L, Pemberton J H, Dozois R R, Ilstrup D, van Heerden J. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis.  Ann Surg. 1990;  211(5) 622-627 discussion 627-629
  • 39 Hata K, Watanabe T, Shinozaki M, Nagawa H. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis.  Scand J Gastroenterol. 2003;  38(10) 1055-1058
  • 40 Fleshner P R, Vasiliauskas E A, Kam L Y et al.. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis.  Gut. 2001;  49(5) 671-677
  • 41 Kuisma J, Järvinen H, Kahri A, Färkkilä M. Factors associated with disease activity of pouchitis after surgery for ulcerative colitis.  Scand J Gastroenterol. 2004;  39(6) 544-548
  • 42 Hui T, Landers C, Vasiliauskas E et al.. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation.  Dis Colon Rectum. 2005;  48(6) 1254-1262
  • 43 Merrett M N, Mortensen N, Kettlewell M, Jewell D O. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis.  Gut. 1996;  38(3) 362-364
  • 44 Shen B, Fazio V W, Remzi F H et al.. Risk factors for diseases of ileal pouch-anal anastomosis in patients with ulcerative colitis.  Clin Gastroenterol Hepatol. 2006;  4 81-89
  • 45 Shen B, Achkar J-P, Lashner B A et al.. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis.  Gastroenterology. 2001;  121(2) 261-267
  • 46 Moskowitz R L, Shepherd N A, Nicholls R J. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir.  Int J Colorectal Dis. 1986;  1(3) 167-174
  • 47 Sandborn W J. Pouchitis: risk factors, frequency, natural history, classification and public health prospective. In: Me Leod RS, Martin F, Sutherland LR, Wallace JL, Williams CN Trends in Inflammatory Bowel Disease 1996. Lancaster, UK; Kluwer Academic Publishers 1997: 51-63
  • 48 Shen B, Remzi F H, Lavery I C, Lashner B A, Fazio V W. A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy.  Clin Gastroenterol Hepatol. 2008;  6(2) 145-158 quiz 124
  • 49 Shen B. Diagnosis and treatment of patients with pouchitis.  Drugs. 2003;  63(5) 453-461
  • 50 Shen B O, Jiang Z-D, Fazio V W et al.. Clostridium difficile infection in patients with ileal pouch-anal anastomosis.  Clin Gastroenterol Hepatol. 2008;  6(7) 782-788
  • 51 Kühbacher T, Ott S J, Helwig U et al.. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.  Gut. 2006;  55(6) 833-841
  • 52 Muñoz-Juarez M, Pemberton J H, Sandborn W J, Tremaine W J, Dozois R R. Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases.  Dis Colon Rectum. 1999;  42(1) 117-120
  • 53 Moonka D, Furth E E, MacDermott R P, Lichtenstein G R. Pouchitis associated with primary cytomegalovirus infection.  Am J Gastroenterol. 1998;  93(2) 264-266
  • 54 Shen B. Campylobacter infection in patients with ileal pouches.  Am J Gastroenterol. 2010;  105(2) 472-473
  • 55 Shen B, Fazio V W, Bennett A E et al.. Effect of withdrawal of non-steroidal anti-inflammatory drug use in patients with the ileal pouch.  Dig Dis Sci. 2007;  52 3321-3328
  • 56 Shen B, Remzi F H, Nutter B et al.. Association between immune-associated disorders and adverse outcomes of ileal pouch-anal anastomosis.  Am J Gastroenterol. 2009;  104(3) 655-664
  • 57 Shen B, Plesec T P, Remer E et al.. Asymmetric endoscopic inflammation of the ileal pouch: a sign of ischemic pouchitis?.  Inflamm Bowel Dis. 2010;  16(5) 836-846
  • 58 Nicholls R J. Review article: ulcerative colitis—surgical indications and treatment.  Aliment Pharmacol Ther. 2002;  16(Suppl 4) 25-28
  • 59 Madden M V, McIntyre A S, Nicholls R J. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis.  Dig Dis Sci. 1994;  39(6) 1193-1196
  • 60 Shen B, Achkar J P, Lashner B A et al.. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.  Inflamm Bowel Dis. 2001;  7(4) 301-305
  • 61 Araki Y, Mitsuyama K, Nagae T et al.. Leukocytapheresis for the treatment of active pouchitis: a pilot study.  J Gastroenterol. 2008;  43(7) 571-575
  • 62 Gionchetti P, Rizzello F, Morselli C et al.. High-dose probiotics for the treatment of active pouchitis.  Dis Colon Rectum. 2007;  50(12) 2075-2082, discussion 2082–2084
  • 63 Shen B, Pardi D S, Bennett A E et al.. The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis.  Am J Gastroenterol. 2009;  104(6) 1468-1474
  • 64 Gionchetti P, Rizzello F, Venturi A et al.. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.  Gastroenterology. 2000;  119(2) 305-309
  • 65 Mimura T, Rizzello F, Helwig U et al.. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.  Gut. 2004;  53(1) 108-114
  • 66 Shen B, Remzi F H, Lopez A R, Queener E. Rifaximin for maintenance therapy in antibiotic-dependent pouchitis.  BMC Gastroenterol. 2008;  8 26 , [electronic journal]
  • 67 Shen B, Brzezinski A, Fazio V W et al.. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice.  Aliment Pharmacol Ther. 2005;  22(8) 721-728
  • 68 Gionchetti P, Rizzello F, Venturi A et al.. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.  Aliment Pharmacol Ther. 1999;  13(6) 713-718
  • 69 Abdelrazeq A S, Kelly S M, Lund J N, Leveson S H. Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis.  Colorectal Dis. 2005;  7(2) 182-186
  • 70 Mimura T, Rizzello F, Helwig U et al.. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.  Aliment Pharmacol Ther. 2002;  16(5) 909-917
  • 71 Shen B, Fazio V W, Remzi F H et al.. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis.  Dis Colon Rectum. 2007;  50(4) 498-508
  • 72 Viscido A, Kohn A, Papi C, Caprilli R. Management of refractory fistulizing pouchitis with infliximab.  Eur Rev Med Pharmacol Sci. 2004;  8(5) 239-246
  • 73 Tremaine W J, Sandborn W J, Wolff B G, Carpenter H A, Zinsmeister A R, Metzger P P. Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial.  Aliment Pharmacol Ther. 1997;  11(6) 1041-1046
  • 74 Wischmeyer P, Pemberton J H, Phillips S F. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study.  Mayo Clin Proc. 1993;  68(10) 978-981
  • 75 Gionchetti P, Rizzello F, Poggioli G et al.. Oral budesonide in the treatment of chronic refractory pouchitis.  Aliment Pharmacol Ther. 2007;  25(10) 1231-1236
  • 76 Calabrese C, Gionchetti P, Rizzello F et al.. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis.  Aliment Pharmacol Ther. 2008;  27(9) 759-764
  • 77 Shen B, Lashner B A, Bennett A E et al.. Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis.  Am J Gastroenterol. 2004;  99(8) 1527-1531
  • 78 Shen B, Lian L, Remzi F H et al.. Natural history of cuffitis in ulcerative colitis patients with restorative proctocolectomy and ileal pouch-anal anastomosis. Poster presented at: Digestive Diseases Week May 1–5, 2010 New Orleans, LA;
  • 79 Panis Y, Poupard B, Nemeth J, Lavergne A, Hautefeuille P, Valleur P. Ileal pouch/anal anastomosis for Crohn's disease.  Lancet. 1996;  347(9005) 854-857
  • 80 Melton G B, Fazio V W, Kiran R P et al.. Long-term outcomes with ileal pouch-anal anastomosis and Crohn's disease: pouch retention and implications of delayed diagnosis.  Ann Surg. 2008;  248(4) 608-616
  • 81 Shen B. Crohn's disease of the ileal pouch: reality, diagnosis, and management.  Inflamm Bowel Dis. 2009;  15(2) 284-294
  • 82 Shen B, Patel S, Lian L. Natural history of Crohn's disease in patients who underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis.  Aliment Pharmacol Ther. 2010;  31(7) 745-753
  • 83 Melmed G Y, Fleshner P R, Bardakcioglu O et al.. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis.  Dis Colon Rectum. 2008;  51(1) 100-108
  • 84 Shen B, Remzi F H, Hammel J P et al.. Family history of Crohn's disease is associated with an increased risk for Crohn's disease of ileal pouch-anal anastomosis.  Inflamm Bowel Dis. 2009;  15 163-170
  • 85 Nasseri Y, Melmed G, Wang H L, Targan S, Fleshner P. Rigorous histopathological assessment of the colectomy specimen in patients with inflammatory bowel disease unclassified does not predict outcome after ileal pouch-anal anastomosis.  Am J Gastroenterol. 2010;  105(1) 155-161
  • 86 Shen B, Fazio V W, Remzi F H et al.. Risk factors for clinical phenotypes of Crohn's disease of the ileal pouch.  Am J Gastroenterol. 2006;  101(12) 2760-2768
  • 87 Colombel J-F, Ricart E, Loftus Jr E V et al.. Management of Crohn's disease of the ileoanal pouch with infliximab.  Am J Gastroenterol. 2003;  98(10) 2239-2244
  • 88 Shen B, Fazio V W, Remzi F H et al.. Endoscopic balloon dilation of ileal pouch strictures.  Am J Gastroenterol. 2004;  99(12) 2340-2347
  • 89 Matzke G M, Kang A S, Dozois E J, Sandborn W J. Mid pouch strictureplasty for Crohn's disease after ileal pouch-anal anastomosis: an alternative to pouch excision.  Dis Colon Rectum. 2004;  47(5) 782-786
  • 90 Shen B, Remzi F H, Lavery I C et al.. Administration of adalimumab in the treatment of Crohn's disease of the ileal pouch.  Aliment Pharmacol Ther. 2009;  29(5) 519-526
  • 91 Shen B, Achkar J-P, Lashner B A et al.. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis.  Am J Gastroenterol. 2002;  97(4) 972-977
  • 92 Shen B, Sanmiguel C, Bennett A E et al.. Irritable pouch syndrome is characterized by visceral hypersensitivity.  Inflamm Bowel Dis. 2010 Aug 3;  , [Epub ahead of print]
  • 93 Shen B, Liu W, Remzi F H et al.. Enterochromaffin cell hyperplasia in irritable pouch syndrome.  Am J Gastroenterol. 2008;  103(9) 2293-2300
  • 94 Freeman H. Dysplasia-associated polypoid mucosal lesion in a pelvic pouch after restorative proctocolectomy for ulcerative colitis.  Can J Gastroenterol. 2001;  15(7) 485-488
  • 95 Negi S S, Chaudhary A, Gondal R. Carcinoma of pelvic pouch following restorative proctocolectomy: report of a case and review of the literature.  Dig Surg. 2003;  20(1) 63-65
  • 96 Laureti S, Ugolini F, D'Errico A, Rago S, Poggioli G. Adenocarcinoma below ileoanal anastomosis for ulcerative colitis: report of a case and review of the literature.  Dis Colon Rectum. 2002;  45(3) 418-421
  • 97 Hyman N. Rectal cancer as a complication of stapled IPAA.  Inflamm Bowel Dis. 2002;  8(1) 43-45
  • 98 Das P, Johnson M W, Tekkis P P, Nicholls R J. Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis.  Colorectal Dis. 2007;  9(1) 15-27
  • 99 Sarigol S, Wyllie R, Gramlich T et al.. Incidence of dysplasia in pelvic pouches in pediatric patients after ileal pouch-anal anastomosis for ulcerative colitis.  J Pediatr Gastroenterol Nutr. 1999;  28(4) 429-434
  • 100 Veress B, Reinholt F P, Lindquist K, Löfberg R, Liljeqvist L. Long-term histomorphological surveillance of the pelvic ileal pouch: dysplasia develops in a subgroup of patients.  Gastroenterology. 1995;  109(4) 1090-1097
  • 101 Heuschen U A, Hinz U, Allemeyer E H et al.. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis.  Gastroenterology. 2001;  120(4) 841-847
  • 102 Gullberg K, Ståhlberg D, Liljeqvist L et al.. Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis.  Gastroenterology. 1997;  112(5) 1487-1492
  • 103 Kariv R, Remzi F H, Lian L et al.. Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy.  Gastroenterology. 2010;  139(3) 806-812 812, e1-e2

Bo ShenM.D. 

Digestive Disease Institute, Desk A31

Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195

Email: shenb@ccf.org

    >